Evan Sumner, Ph.D., focuses his practice on patent litigation in the areas of pharmaceuticals, biologics, and medical devices. Evan has extensive experience in Hatch-Waxman litigation and leverages his technical background in pharmacology to effectively represent pharmaceutical companies in complex Abbreviated New Drug Application cases.
Evan manages all stages of District Court litigation, including pre-suit investigations, infringement/invalidity contentions, claim construction, fact and expert discovery, pre-trial motions, trial, and post-trial briefing. Prior to practicing law, Evan served as an extern at the United States Patent and Trademark Office, where he examined patent applications and prepared office actions. He uses this experience to help clients evaluate their patent portfolios in anticipation of litigation.
Evan’s technical background is in the life sciences, with significant academic and research experience in the fields of pharmacology, cell and molecular biology, and drug design.
